Search

Search Constraints

You searched for: Author/Creator Vitanza, Nicholas A

Search Results

1. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Issue 1 (28th August 2018)

2. DIPG-07. Preclinical and case study results underpinning the phase II clinical trial testing the combination of ONC201 and paxalisib for the treatment of patients with diffuse midline glioma (NCT05009992). (3rd June 2022)

3. DIPG-64. INTERNATIONAL PRECLINICAL DRUG DISCOVERY AND BIOMARKER PROGRAM INFORMING AN ADOPTIVE COMBINATORIAL TRIAL FOR DIFFUSE MIDLINE GLIOMAS. (4th December 2020)

4. EPCT-03. SERIAL PLASMA AND CSF CELL-FREE TUMOR DNA (CF-TDNA) TRACKING IN DIFFUSE MIDLINE GLIOMA PATIENTS UNDERGOING TREATMENT WITH ONC201. (1st June 2021)

5. GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY. Issue 2 (22nd June 2018)

6. GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY. Issue 2 (22nd June 2018)

7. HGG-24. PRECLINICAL EFFICACY OF THE BRAIN PENETRANT CYCLIN-DEPENDENT KINASE INHIBITOR ZOTIRACICLIB IN PEDIATRIC DIFFUSE MIDLINE GLIOMAS. (1st June 2021)

8. HGG-32. ONC201 AND ONC206 TARGET TUMOR CELL METABOLISM IN PEDIATRIC DIFFUSE MIDLINE GLIOMA PRECLINICAL MODELS. (1st June 2021)

9. Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas. Issue 9 (14th February 2022)

10. Machine Assist for Pediatric Posterior Fossa Tumor Diagnosis: A Multinational Study. Issue 5 (14th August 2021)